Cours Arizona Gold and Onyx Mining Co OTC Bulletin Board
Actions
Produits pharmaceutiques
CA 2020 | - | CA 2021 | - | Capitalisation | 170 M 154 M |
---|---|---|---|---|---|
Résultat net 2020 | -9 M -8,15 M | Résultat net 2021 | -78 M -70,66 M | VE / CA 2020 | - |
Trésorerie nette 2020 * | - 0 | Dette nette 2021 | 97,31 k 88,15 k | VE / CA 2021 | - |
PER 2020 |
-94,8
x | PER 2021 |
-2,54
x | Employés | - |
Rendement 2020 * |
-
| Rendement 2021 |
-
| Flottant | 18,04% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Sara Gonzales
CEO | Chief Executive Officer | 51 | - |
President | 68 | 01/01/09 | |
Shujie Cui
CTO | Chief Tech/Sci/R&D Officer | 62 | 05/12/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
President | 68 | 01/01/09 | |
Shujie Cui
CTO | Chief Tech/Sci/R&D Officer | 62 | 05/12/19 |
Sara Gonzales
CEO | Chief Executive Officer | 51 | - |
Varia. 1 janv. | Capi. | |
---|---|---|
+30,38% | 684 Md | |
+26,51% | 568 Md | |
-4,36% | 361 Md | |
+19,30% | 329 Md | |
+3,73% | 284 Md | |
+16,70% | 240 Md | |
+8,78% | 208 Md | |
-7,93% | 200 Md | |
+7,68% | 166 Md |